Form 4: Vericel Corp CEO Dominick Colangelo Executes Stock Options and Sells Shares Under 10b5-1 Plan

Vericel Corp's CEO, Dominick Colangelo, exercised stock options and sold shares of common stock on April 17 and 18, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Dominick Colangelo, the President and CEO of Vericel Corp, executed stock options to purchase 17,500 shares of common stock on both April 17 and April 18, 2024, at an exercise price of $3.02 per share.
• Simultaneously, Colangelo sold 17,500 shares of common stock on each of those days at prices of $46.47 and $44.59, respectively.
• These transactions were conducted under a Rule 10b5-1 trading plan adopted on September 1, 2023.
• Following these transactions, Colangelo directly owns 195,307 shares of Vericel Corp common stock.
• He also holds options to purchase 245,000 additional shares.

Sentiment

Score: 5

Explanation: Neutral sentiment as the document simply reports transactions. The use of a 10b5-1 plan suggests pre-planned and orderly transactions.

Industry Context

This filing is a routine disclosure of insider trading activity. It is common for executives to use Rule 10b5-1 plans to sell shares over time to avoid accusations of trading on inside information.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the increased supply of shares in the market.

Key Dates